The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Volume 302, Issue 1, Pages H231-H243
Publisher
American Physiological Society
Online
2011-11-05
DOI
10.1152/ajpheart.00665.2011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Negative Inotropic Effect of Rapamycin on Isolated Human Cardiomyocytes
- (2013) H Möllmann et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- LEOPARD-type SHP2 mutant Gln510Glu attenuates cardiomyocyte differentiation and promotes cardiac hypertrophy via dysregulation of Akt/GSK-3β/β-catenin signaling
- (2011) Hidekazu Ishida et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- mTOR Signalling in Health and Disease: Figure 1
- (2011) Christopher G. Proud BIOCHEMICAL SOCIETY TRANSACTIONS
- Cardiac Raptor Ablation Impairs Adaptive Hypertrophy, Alters Metabolic Gene Expression, and Causes Heart Failure in Mice
- (2011) Pankaj Shende et al. CIRCULATION
- Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome–associated PTPN11 mutation
- (2011) Talita M. Marin et al. JOURNAL OF CLINICAL INVESTIGATION
- mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy
- (2010) Xiaoxiao Song et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice
- (2010) Denghong Zhang et al. JOURNAL OF CLINICAL INVESTIGATION
- Functional Effects of PTPN11 (SHP2) Mutations Causing LEOPARD Syndrome on Epidermal Growth Factor-Induced Phosphoinositide 3-Kinase/AKT/Glycogen Synthase Kinase 3 Signaling
- (2010) T. Edouard et al. MOLECULAR AND CELLULAR BIOLOGY
- Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome
- (2010) Xonia Carvajal-Vergara et al. NATURE
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- PTPN11 Gene Mutation and Severe Neonatal Hypertrophic Cardiomyopathy: What Is the Link?
- (2009) Maria Felicia Faienza et al. PEDIATRIC CARDIOLOGY
- Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation
- (2009) T. Araki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genotype–phenotype analysis and natural history of left ventricular hypertrophy in LEOPARD syndrome
- (2008) Giuseppe Limongelli et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Shp2 Negatively Regulates Growth in Cardiomyocytes by Controlling Focal Adhesion Kinase/Src and mTOR Pathways
- (2008) Talita M. Marin et al. CIRCULATION RESEARCH
- MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
- (2008) Thomas Thum et al. NATURE
- Role of ERK1/2 signaling in congenital valve malformations in Noonan syndrome
- (2008) M. Krenz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sirolimus As Primary Immunosuppressant Reduces Left Ventricular Mass and Improves Diastolic Function of the Cardiac Allograft
- (2008) Eugenia Raichlin et al. TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search